Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Phenotyping and preventing Congenital Diaphragmatic Hernia (CDH) defects in a novel mouse model with abnormal retinoic acid signalling in the developing diaphragm.

EF 2023-24

Résumé
Congenital Diaphragmatic Hernia (CDH) is a structural birth defect where the diaphragm does not develop fully in utero, allowing the abdominal organs to move into the thorax impinging lung development. It occurs frequently in North America (1:2200 live births), and carries 4-times the health care burden compared to age and illness severity matched infants. Over the last 25 years, neonatal care improvements have increased CDH survival rates from 50% to 80%, but our limited understanding of its pathogenesis has kept CDH prevalence at a plateau. Therefore, the objective of my project is to better understand CDH pathogenesis. Curiously, current animal models of CDH share common pathogenic pathways: (1) the defect originates in the embryonic mesenchyme which becomes the diaphragm's connective tissue, and (2) Vitamin A signaling is important during gestation for normal diaphragm development. Despite these findings, no animal model has tested these two concepts together until our development of the Prrx1-Cre:Rar mouse model, which blocks vitamin A signaling in the diaphragmatic mesenchyme. Preliminary results show this model has 100% incidence of CDH. My project will leverage this model and answer: (1) What are the gross to cellular differences between control and CDH diaphragms? And (2) Can acute and chronic Vitamin A modulation in a pregnant dam rescue CDH incidence in her offspring? This research will phenotype the first animal model of CDH with 100% incidence, providing an important new tool to the field. Moreover, our approach highlights the importance of mesenchymal Vitamin A signaling in CDH pathogenesis and how to experimentally rescue CDH. This work will provide new insight into the mechanisms of CDH with the future potential to be translated into the clinic.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
505851
Name
Applin Nicole H
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Phenotyping and preventing Congenital Diaphragmatic Hernia (CDH) defects in a novel mouse model with abnormal retinoic acid signalling in the developing diaphragm.
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Animal Models Of Disease; Congenital Diaphragmatic Hernia; Developmental Physiology; Diaphragm Development; Embryology; Etiology; Gene-Nutrient Interactions; Pathogenesis; Retinoids; Vitamin A
Abstract
Congenital Diaphragmatic Hernia (CDH) is a structural birth defect where the diaphragm does not develop fully in utero, allowing the abdominal organs to move into the thorax impinging lung development. It occurs frequently in North America (1:2200 live births), and carries 4-times the health care burden compared to age and illness severity matched infants. Over the last 25 years, neonatal care improvements have increased CDH survival rates from 50% to 80%, but our limited understanding of its pathogenesis has kept CDH prevalence at a plateau. Therefore, the objective of my project is to better understand CDH pathogenesis. Curiously, current animal models of CDH share common pathogenic pathways: (1) the defect originates in the embryonic mesenchyme which becomes the diaphragm's connective tissue, and (2) Vitamin A signaling is important during gestation for normal diaphragm development. Despite these findings, no animal model has tested these two concepts together until our development of the Prrx1-Cre:Rar mouse model, which blocks vitamin A signaling in the diaphragmatic mesenchyme. Preliminary results show this model has 100% incidence of CDH. My project will leverage this model and answer: (1) What are the gross to cellular differences between control and CDH diaphragms? And (2) Can acute and chronic Vitamin A modulation in a pregnant dam rescue CDH incidence in her offspring? This research will phenotype the first animal model of CDH with 100% incidence, providing an important new tool to the field. Moreover, our approach highlights the importance of mesenchymal Vitamin A signaling in CDH pathogenesis and how to experimentally rescue CDH. This work will provide new insight into the mechanisms of CDH with the future potential to be translated into the clinic.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Applin, Nicole H
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~